Dr. Arnolfo Mastelli discovered a patented drug, an extract rich in DNA, with remarkable regenerative capabilities.
Trusting his vision, he first marketed it and then secured the exclusive production license.
The newly established Dr. A. Mastelli Laboratory swiftly became a pharmaceutical company, destined to be renowned for its efforts in regenerative medicine up to the present day.
Starting in the 1970s, Dr Oliviero Cattarini Mastelli and his wife Dr Claudia Torlasco, brought new luster to the company through their tireless interest in understanding the wondrous effects of the famed drug.
First in academia, and later with the birth of internal R&D, they magnified the role of Polydeoxyribonucleotides,
the molecule understood as the main tissue regeneration activator
In 2005, the third Mastelli generation, always working closely with the scientific community, discovered a new molecule, Polynucleotides, and turned it into a game-changer worldwide, from aesthetics to orthopedics.
The first PN HPT®-based registered medical device was born.
In 2016, the perfect union - PN fell in love with hyaluronic acid, bringing a whole new product line to life, dedicated to dehydrated and mature skin
The year of takeoff, a new identity, the unwavering desire to regenerate, again, and again...
With a new regeneration endeavor already underway: the construction of the Polynucleotides Hub in 2025. Always in Italy, always in Sanremo.
Always steered by the family’s compass.